Category: Jurisdictions
-
Ibex sues Disney and Snap in Brazil as streaming patent disputes escalate
Ibex has launched separate patent actions in Brazil against Disney and Snap relating to video technologies, adding to growing litigation pressure on video streamers across multiple jurisdictions.
-
Brazilian court lifts ZTE’s 5G injunction against Samsung as expert rejects infringement and essentiality claims
A Rio de Janeiro court revoked ZTE’s 5G injunction against Samsung after a court-appointed expert concluded that the asserted patent is neither infringed nor essential to the 5G NR standard.
-
Podcast: interview with Dr. Peter Georg Picht, SEP and competition law expert
In our latest podcast episode, ip fray interviewed Dr. Peter Georg Picht, an IP and competition law professor at Zurich University, and a fellow with the Max Planck Institute for Innovation and Competition.
-
BREAKING: Nokia and Geely settled cellular SEP dispute; unknown if pool or bilateral license
A trial (with the possibility of a subsequent bench ruling) was scheduled for today, but canceled on short notice.
-
Samsung leads U.S. AI patent grants 2025, otherwise largely dominated by Big Tech
Meanwhile, 12 of the top 100 U.S. AI patent holders are automakers, meaning AI is becoming front and center of the car manufacturing industry, a report by Harrity Patent Analytics has revealed.
-
ByteDance faces litigation on multiple fronts from Dominion Harbor entities asserting SEPs and non-SEPs
Lark, ByteDance’s workplace collaboration platform, has been targeted; while TikTok and virtual reality gear maker Pico have also been sued.
-
Brazilian appeals court keeps connected-car injunction against GWM in force
A Rio de Janeiro appellate judge refused to stay a connected-car SEP injunction against five GWM vehicle models, keeping restrictions on 4G connectivity services in place during the appeal.
-
Federal Circuit says owners of patents subject to exclusive license still have standing to sue where terms don’t render rights “illusory”
A.L.M. and Ergon granted wide-ranging rights to an exclusive licensee – but retained the right to sue third-party infringers.
-
Pharma giant Takeda ordered to pay over $884 million in damages in Amitiza class action suit: patent litigation settlement was anticompetitive, jury finds
Takeda has said it already plans to “vigorously” appeal the decision, which found its 2014 deal with competitor Par Pharmaceutical to drop its challenge to its AMITIZA patents and delay its generic entry by seven years, anticompetitive.